HIV postexposure prophylaxis during COVID-19.
Muhammad Junejo, Nicolo Girometti, Alan McOwan, Gary Whitlock, Dean Street Collaborative Group
Author Information
- Muhammad Junejo: 56 Dean Street, Chelsea and Westminster Hospital National Health Service Foundation Trust, London W1D 6AQ, UK.
- Nicolo Girometti: 56 Dean Street, Chelsea and Westminster Hospital National Health Service Foundation Trust, London W1D 6AQ, UK.
- Alan McOwan: 56 Dean Street, Chelsea and Westminster Hospital National Health Service Foundation Trust, London W1D 6AQ, UK.
- Gary Whitlock: 56 Dean Street, Chelsea and Westminster Hospital National Health Service Foundation Trust, London W1D 6AQ, UK. Electronic address: gary.whitlock@chelwest.nhs.uk.
No abstract text available.
- Int J STD AIDS. 2016 Aug;27(9):713-38
[PMID: 27095790]
Adult
Anti-HIV Agents
Betacoronavirus
COVID-19
Coinfection
Coronavirus Infections
Drug Prescriptions
Female
HIV
HIV Infections
Humans
Male
Pandemics
Physical Distancing
Pneumonia, Viral
Post-Exposure Prophylaxis
Prescription Drug Monitoring Programs
SARS-CoV-2
Sexual Partners
United Kingdom
